Abstract
IntroductionWhether gastric cancer (GC) patients with deficient mismatch repair or microsatellite instability-high (dMMR/MSI-H) benefit from perioperative (neoadjuvant and/or adjuvant) chemotherapy is controversial. This protocol delineates the planned scope and methods...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have